Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group†   H. Goossens  Clinical.

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents
Development of resistance in Pseudomonas aeruginosa obtained from patients with cystic fibrosis at different times  F.B. Spencker, L. Staber, T. Lietz,
L. Boyanova  Clinical Microbiology and Infection 
An outbreak of hospital-acquired Pseudomonas aeruginosa infection caused by contaminated bottled water in intensive care units  T. Eckmanns, M. Oppert,
I.J. Schalk  Clinical Microbiology and Infection 
Salvage therapy for multidrug-resistant tuberculosis
Approach to diagnosis of infective endocarditis
D. Khalil, M. Hultin, M.U. Rashid, B. Lund 
Antimicrobial resistance in viridans group streptococci among patients with and without the diagnosis of cancer in the USA, Canada and Latin America 
Time-trends for Gram-negative and multidrug-resistant Gram-positive bacteria associated with nosocomial infections in German intensive care units between.
Control of multidrug-resistant Gram-negative bacteria in low- and middle-income countries—high impact interventions without much resources  N. Singh,
Herpes zoster in non-hospitalized children
A.K. Reddy, P. Garg, I. Kaur  Clinical Microbiology and Infection 
Candida glabrata fungaemia in intensive care units
Nosocomial spread of Pseudomonas aeruginosa producing the metallo-β-lactamase VIM-2 in a Spanish hospital: clinical and epidemiological implications 
Genital Chlamydia trachomatis infections
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Pan-drug-resistant Pseudomonas aeruginosa causing nosocomial infection at a university hospital in Taiwan  P.R. Hsueh, S.P. Tseng, L.J. Teng, S.W. Ho 
Surveillance of Legionnaires’ disease in Austria
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
A multicentre analysis of epidemiology of the nosocomial bloodstream infections in Japanese university hospitals  M. Nagao  Clinical Microbiology and.
H. Adibhesami, M. Douraghi, M. Rahbar, A. Abdollahi 
Serotypes, biotypes and antimicrobial susceptibilities of Haemophilus influenzae isolated from invasive disease in children in Casablanca  N. Moustaoui,
Vector control: a cornerstone in the malaria elimination campaign
C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins
Sofie Arens, Jan Verhaegen, Ludo Verbist 
C. Peña, M.A. Dominguez, M. Pujol, R. Verdaguer, F. Gudiol, J. Ariza 
A. Oliver, A. Mena  Clinical Microbiology and Infection 
Multicenter study of the in vitro activity of cefepime in comparison with five other broad- spectrum antibiotics against clinical isolates of Gram-positive.
Training for the infectious diseases speciality in Norway
E.C. Böttger  Clinical Microbiology and Infection 
Laboratory diagnosis and biosafety issues of biological warfare agents
Salvage therapy for multidrug-resistant tuberculosis
Strategies for managing today's infections
In vitro selection of antibiotic resistance in Pseudomonas aeruginosa
Combating the spread of carbapenemases in Enterobacteriaceae: a battle that infection prevention should not lose  P. Savard, T.M. Perl  Clinical Microbiology.
Isolation rate, T-serotyping and susceptibility to antibiotics of Group A Streptococcus from pediatric infections in Athens*   M. Kanellopoulou, A. Makri,
Metagenomics and probiotics
Advisory group on Home-based and Outpatient Care (AdHOC): an international consensus statement on non-inpatient parenteral therapy  D. Nathwani, J.-J.
Effect of antioxidants on the immune response of Helicobacter pylori
MIC distribution and inoculum effect of LY333328: a study of vancomycin-susceptible and VanA-type and VanC-type enterococci obtained from intensive care.
Laboratory diagnosis of Clostridium difficile disease
S8 – S47 and O50 – O440 Clinical Microbiology and Infection
G.R. Davies  Clinical Microbiology and Infection 
A. Bryskier  Clinical Microbiology and Infection 
T.M. File  Clinical Microbiology and Infection 
Molecular epidemiology of Pseudomonas aeruginosa in intensive care units over a 10- year period ( )  M. Cuttelod, L. Senn, V. Terletskiy, I. Nahimana,
Update on antifungal resistance in Aspergillus and Candida
Abstracts cont. Clinical Microbiology and Infection
Comparative antimicrobial spectrum and activity of the desfluoroquinolone BMS (T-3811) tested against non-fermentative Gram-negative bacilli  W.
Training in infectious diseases and tropical medicine in Britain
Circulation of international clones of levofloxacin non-susceptible Streptococcus pneumoniae in Taiwan  Y.-C. Hsieh, L.-Y. Chang, Y.-C. Huang, H.-C. Lin,
Clinical infection services—the Leiden experience
Statin use and clinical outcomes among pneumonia patients
Clinical Microbiology and Infection
Clinical Microbiology and Infection
W. Eugene Sanders, Christine C. Sanders 
Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe  Robert D. Fox  Clinical Microbiology.
Abstracts Clinical Microbiology and Infection
New oral cephalosporins in pediatric community-acquired infections
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
The DUEL study: a multi-center in vitro evaluation of linezolid compared with other antibiotics in the Netherlands  J.W. Mouton, A.R. Jansz  Clinical.
New patterns of HIV-1 resistance during HAART
Joshua P. Metlay, Daniel E. Singer  Clinical Microbiology and Infection 
Impact of a targeted isolation strategy at intensive-care-unit-admission on intensive- care-unit-acquired infection related to multidrug-resistant bacteria:
B. Martha, D. Croisier, A. Fanton, K. Astruc, L. Piroth, F. Huet, P
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Presentation transcript:

Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group†   H. Goossens  Clinical Microbiology and Infection  Volume 9, Issue 9, Pages 980-983 (September 2003) DOI: 10.1046/j.1469-0691.2003.00690.x Copyright © 2003 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 1 Cumulative percentage inhibition of multi-drug-resistant isolates of Pseudomonas aeruginosa from ICUs (n = 57). Clinical Microbiology and Infection 2003 9, 980-983DOI: (10.1046/j.1469-0691.2003.00690.x) Copyright © 2003 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 2 Cumulative percentage inhibition of non-multidrug resistant isolates of P. aeruginosa from ICUs (n = 998). Clinical Microbiology and Infection 2003 9, 980-983DOI: (10.1046/j.1469-0691.2003.00690.x) Copyright © 2003 European Society of Clinical Infectious Diseases Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.